Leaflet REVITUS EXPECTORANT 200mg capsules

Indicated for: viscous bronchial secretions; paracetamol overdose

Route of administration: oral

Substance: acetylcysteine (mucolytic)

ATC: R05CB01 (Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics)

Precautions:
Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Acetylcysteine is a medication primarily used as a mucolytic to thin and loosen thick, viscous mucus in the airways, making it easier to expel. It is indicated for respiratory conditions such as chronic bronchitis, bronchiectasis, cystic fibrosis, or pneumonia.

Additionally, acetylcysteine is used as an antidote in cases of paracetamol (acetaminophen) overdose, as it helps restore glutathione levels in the liver, protecting liver cells from damage.

The medication can be administered orally, intravenously, or via inhalation, depending on the indication. Common side effects include nausea, vomiting, diarrhea, or respiratory tract irritation. In rare cases, it may cause severe allergic reactions, such as anaphylactic shock.

Acetylcysteine is an effective and safe medication when used as directed by a healthcare provider. Patients should adhere to the prescribed dosage and inform their doctor of any adverse reactions.

General data about REVITUS EXPECTORANT 200mg

  • Substance: acetylcysteine
  • Date of latest medicines list: 01-03-2017
  • Product code: W63140001
  • Concentration: 200mg
  • Pharmaceutical form: capsules
  • Quantity: 20
  • Product type: Generic medicine
  • Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

  • Manufacturer: LAROPHARM S.R.L. - ROMANIA
  • Holder: SOLACIUM PHARMA S.R.L. - ROMANIA
  • Number: 6922/2014/01
  • Shelf life: 3 years

Concentrations available for acetylcysteine

  • 100mg
  • 100mg/5ml
  • 2%
  • 200mg
  • 200mg/ml
  • 20mg/ml
  • 300mg/3ml
  • 5%
  • 600mg